The Benefits of Intravitreal Steroids During Vitrectomy

• by John W. Kitchens, MD

• July 1, 2026

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry

• by Jurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, Paolo Sfriso, Sara Bindoli, Pravin Hissaria, Mark Beecher, José Hernández-Rodríguez, Verónica Gómez-Caverzaschi, Micol Frassi, Francesca Crisafulli, Lorenzo Dagna, Corrado Campochiaro, Serena Bugatti, Alessandra Milanesi, Guillermo Ruiz-Irastorza, Adriana Soto-Peleteiro, Matteo Piga, Ombretta Viapiana, Abdurrahman Tufan, Ertugrul Cagri Bolek, Paola Triggianese, Marcella Prete, Jessica Sblachiero, Valeria Caggiano, Antonio Vitale, Henrique Ayres Mayrink Giardini, Giuseppe Lopalco, Fabrizio Conti, Paolo Moscato, Chiara Cardamone, Ewa Wiesik-Szewczy, Andrés González-García, Amato De Paulis, Rosetta Vitetta, Perla Ayumi Kawakami-Campos, Alessandra Brancaleoni, Andrea Mercanti, Alessandra Renieri, Monica Bocchia, Gaafar Ragab, Vishali Gupta, Alejandra de-la-Torre, Bruno Frediani, Carmelo Gurnari, Luca Cantarini, Claudia Fabiani

• June 19, 2026

Meta-analysis of the association between retinopathy and the risk of stroke

• by Lingyun Wu, Weifeng Jiang

• June 30, 2026

Emphasis on Vitreoretinal Surgery

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

• by Diana V. Do, MD

• July 1, 2026

• 3 min